ARTICLE | Clinical News
EDP-239: Phase I
September 1, 2014 7:00 AM UTC
Novartis began an open-label Phase I trial evaluating alisporivir in combination with EDP-239 in about 42 healthy volunteers. EDP-239 is in Phase I testing to treat HCV infection. Alisporivir, an olig...